Enhanced nutrition improves growth and increases blood adiponectin concentrations in very low birth weight infants

Elin W Blakstad1,2,3, Sissel J Moltu4,5, Britt Nakstad1,2

  • 1Department of Pediatric and Adolescent Medicine, Akershus University Hospital, Lørenskog, Norway.

Food & Nutrition Research
|December 4, 2016
PubMed

Insights

Enhanced nutrition improved early growth in very low birth weight (VLBW) infants, potentially preventing later catch-up growth. Higher adiponectin levels in the intervention group correlated with better early weight gain and nutrient intake.

Area of Science:

  • Neonatal nutrition
  • Pediatric growth and development
  • Metabolic health in infancy

Background:

  • Optimal postnatal growth is crucial for very low birth weight (VLBW) infants.
  • Early growth trajectories may impact long-term metabolic syndrome risk.

Purpose of the Study:

  • To assess the impact of enhanced nutrient supply on growth and metabolic markers in VLBW infants.
  • To evaluate adiponectin, leptin, and insulin-like growth factor-1 (IGF-1) levels in response to nutritional intervention.

Main Methods:

  • Randomized controlled trial involving 50 VLBW infants.
  • Intervention group received enhanced nutrient supply; control group received standard supply.
  • Growth and metabolic markers measured up to 2 years corrected age.

Main Results:

  • Significant differences in weight and head growth between groups from birth to 2 years corrected age.
  • Enhanced nutrition improved early growth z-scores, while controls experienced a decline followed by catch-up.
  • Higher adiponectin levels observed in the intervention group at 5 months, correlating with weight gain and nutrient intake.

Conclusions:

  • Enhanced nutrient supply positively influenced early postnatal growth in VLBW infants.
  • Adiponectin levels at 5 months were associated with early nutrition and growth.
  • Early nutritional strategies may influence infant metabolic profiles.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
411
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
605
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.6K
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
1.3K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
340